Browse Category

Reliance Industries News 17 October 2025 - 27 November 2025

Reliance Industries Share Price Today (27 November 2025): RIL Holds Near Record High as ₹21 Lakh Crore Story Meets $11 Billion AI Data Centre Bet

Reliance Industries Share Price Today (27 November 2025): RIL Holds Near Record High as ₹21 Lakh Crore Story Meets $11 Billion AI Data Centre Bet

Reliance Industries Limited (RIL) spent Thursday’s session consolidating near record levels after a powerful two‑day rally that pushed its market capitalisation past the ₹21 lakh crore mark and set fresh 52‑week highs. The stock is now trading in a tight range at the very top of its one‑year band, with investors weighing recent big-ticket capex announcements and supportive brokerage commentary against stretched short‑term valuations. Reliance Industries share price today, 27 November 2025 On Thursday, 27 November 2025, Reliance Industries opened strong at ₹1,575 and traded between roughly ₹1,556 and ₹1,575.5 on the NSE. According to end‑of‑day data, the stock closed
Reliance Q2 Results Boost Investor Hopes – Double-Digit Growth, Jio IPO Buzz & Stock Breakout?

Reliance Q2 Results Boost Investor Hopes – Double-Digit Growth, Jio IPO Buzz & Stock Breakout?

RIL Q2 Earnings Signal Steady Growth Across Businesses Mumbai, Oct 17, 2025 (News Report): Reliance Industries – India’s largest company by market value – announced its July–September quarter results on Friday, delivering a solid performance amid high investor expectations. Early indications from brokerage estimates suggest double-digit growth in both profit and revenue for Q2 FY2026, driven by strength in RIL’s core businesses. Analysts had widely predicted a “healthy double-digit rise in consolidated revenue and profit” year-on-yearlivemint.com, and RIL appears to have largely met those optimistic forecasts. This comes after an extraordinary Q1 where Reliance booked record profits thanks to a

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Go toTop